These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20853354)

  • 41. Device closure of iatrogenic membranous ventricular septal defects after prosthetic aortic valve replacement using the Amplatzer membranous ventricular septal defect occluder.
    Holzer R; Latson L; Hijazi ZM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):276-80. PubMed ID: 15170726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcatheter closure of a traumatic ventricular septal defect.
    Guérin P; Langlard JM; Roussel JC
    Arch Cardiovasc Dis; 2010; 103(6-7):419-20. PubMed ID: 20800807
    [No Abstract]   [Full Text] [Related]  

  • 43. Retrograde use of the Cardioseal/Starflex occluder device.
    Jux C; Schneider M; Paul T
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):448-54. PubMed ID: 15926174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utilization of 3 amplatzer occluders for closure of post-myocardial infarction ventricular septal defect.
    Kar S; Ibebuogu UN; Conte AH
    J Invasive Cardiol; 2012 May; 24(5):E101-3. PubMed ID: 22562925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association.
    Sarris GE; Kirvassilis G; Zavaropoulos P; Belli E; Berggren H; Carrel T; Comas JV; Corno AF; Daenen W; Di Carlo D; Ebels T; Fragata J; Hamilton L; Hraska V; Jacobs J; Lazarov S; Mavroudis C; Metras D; Rubay J; Schreiber C; Stellin G
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1285-90. PubMed ID: 20353896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter Closure of a Traumatic VSD with an ASD Occluder.
    Santos RAPD; Guedes H; Marques L; Lourenço C; Silva JC; Pinto P
    Arq Bras Cardiol; 2018 Aug; 111(2):223-225. PubMed ID: 30183991
    [No Abstract]   [Full Text] [Related]  

  • 47. Closure of an iatrogenic ventricular septal defect using a hybrid approach and echocardiographic guidance.
    Parsons C; Zhao CB; Huang J
    Ann Card Anaesth; 2020; 23(2):212-215. PubMed ID: 32275038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Traumatic ventricular septal defect and flail tricuspid valve: successful management by an extracorporeal membrane oxygenator-supported hybrid approach.
    Ling FS; Massey HT
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):655-60. PubMed ID: 23728953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous closure of a traumatic ventricular septal defect after transcatheter aortic valve implantation.
    Baruteau AE; Petit J
    Ann Thorac Surg; 2014 Mar; 97(3):1081. PubMed ID: 24580933
    [No Abstract]   [Full Text] [Related]  

  • 50. Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe?
    Diab K; Kenny D; Hijazi ZM
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):168-74. PubMed ID: 22718680
    [No Abstract]   [Full Text] [Related]  

  • 51. Transcatheter closure of a traumatic ventricular septum defect resulting from a stab wound.
    Dedic A; Nieman K; Bogers AJ; Witsenburg M
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):96-9. PubMed ID: 24585940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Over-the-wire-technique device implantation.
    Butera G; Castaldi B; Macdonald ST
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):485-92. PubMed ID: 22511555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous closure of a postinfarction ventricular septal defect and an iatrogenic left ventricular free-wall perforation using two Amplatzer muscular VSD occluders.
    Eshtehardi P; Garachemani A; Meier B
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):243-6. PubMed ID: 19405157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transradial and transfemoral percutaneous closure of iatrogenic perimembranous Ventricular Septal Defects using the Amplatzer AVP IV device.
    Weeraman D; Hilling-Smith R; Dooley M; Hildick-Smith D
    Int J Cardiol; 2016 Dec; 224():65-68. PubMed ID: 27614240
    [No Abstract]   [Full Text] [Related]  

  • 55. Aortic valve leaflet entrapment by a percutaneous closure device.
    Tuluca A; Omer S; Cornwell L; Blaustein A; Kar B; Weldon S; Bakaeen FG
    Ann Thorac Surg; 2014 Jul; 98(1):e23-5. PubMed ID: 24996746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful repair of a traumatic ventricular septal defect using an amplatzer occluder guided by three-dimensional transesophageal echocardiography.
    Zhu D; Tao KY; Liu B
    J Card Surg; 2010 Nov; 25(6):685-9. PubMed ID: 21070353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of the Gore Septal Occluder in Transcatheter Closure of Post-Myocardial Infarct Ventricular Septal Defect: Initial Experience.
    Arias EA; Bhan A; Lim ZY; Mullen M
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2259-2261. PubMed ID: 27832852
    [No Abstract]   [Full Text] [Related]  

  • 58. Amplatzer septal occluder sealed the complicating aortic root perforation during transseptal procedure.
    Hartono B; Razakjr OA; Munawar M
    JACC Cardiovasc Interv; 2012 Apr; 5(4):450-1. PubMed ID: 22516404
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute urinary retention following percutaneous interventions in individuals with congenital heart disease.
    Davy J; Spargo P; Veldtman G
    J Invasive Cardiol; 2011 Apr; 23(4):E79-82. PubMed ID: 21474858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seven Coils in 1 Heart: Therapeutic Option for Multiple VSD.
    Sabiniewicz R; Weryński P
    JACC Cardiovasc Interv; 2017 Apr; 10(8):837-838. PubMed ID: 28365261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.